New approaches to delivery of fluorides.
Shern
R J
RJ
Clinical Investigations and Patient Care Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, MD, USA.
D000818:Animals; D002130:Calcium Phosphates / Q000008:administration & dosage; D002327:Cariostatic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D003692:Delayed-Action Preparations; D003743:Dental Enamel / Q000378:metabolism; D016503:Drug Delivery Systems; D005459:Fluorides / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D005460:Fluorides, Topical / Q000008:administration & dosage / Q000493:pharmacokinetics; D006801:Humans; D012463:Saliva / Q000737:chemistry
D002130:Calcium Phosphates; D002327:Cariostatic Agents; D003692:Delayed-Action Preparations; D005460:Fluorides, Topical; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous; D005459:Fluorides